Robust biomarker identification for cancer diagnosis with ensemble feature selection methods

Area of Science:

• Computational biology
• Biomedical data analysis

Background:

• Biomarker discovery from high-dimensional data is crucial but lacks robustness.
• The stability of gene and SNP selection methods is a recent but critical concern for biological validation and expert confidence.

Purpose of the Study:

• To introduce a general framework for analyzing the robustness of biomarker selection algorithms.
• To evaluate ensemble feature selection for improving the robustness and performance of Support Vector Machine (SVM)-based biomarker discovery.

Main Methods:

• Developed a general framework for assessing biomarker selection robustness.
• Applied and analyzed ensemble feature selection techniques combined with SVMs for gene selection.
• Evaluated the methodology on four diverse microarray datasets.

Main Results:

• Ensemble feature selection significantly increases the robustness of SVM-based biomarker discovery.
• Classification performance was improved by approximately 15% alongside robustness gains.
• Robustness improvements of up to 30% were observed, particularly for small gene signature sizes.

Conclusions:

• Ensemble feature selection is a powerful strategy to enhance biomarker discovery robustness and predictive accuracy.
• This method increases confidence in selected biomarkers, crucial for developing reliable diagnostic and prognostic models.
• The findings are particularly relevant for designing gene signature-based diagnostic tools.